SAN DIEGO, Sept. 23 /PRNewswire-FirstCall/ -- Biosite Incorporated
(Nasdaq: BSTE) today announced that Gunars Valkirs, senior vice president of
Discovery, and Chris Twomey, senior vice president of finance and chief
financial officer, will discuss the Company's operating environment, new and
potential products and the company's research and development activities at
the 2005 UBS Life Science Conference. Biosite's presentation will take place
Wednesday, September 28th, 2005, at 10:30 a.m. Pacific. The conference is to
be held at the Grand Hyatt Hotel in New York.
A link to the live audio webcast can be accessed through the Biosite
website, http://www.biosite.com. The Biosite presentation will be archived on the
website until October 29, 2005 in the Investor and Media section under Events
Calendar.
About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis. The
Company's products contribute to improvements in medical care by aiding
physicians in the diagnosis of critical diseases and health conditions.
Biosite's Triage(R) rapid diagnostics are used in approximately 50 percent of
U.S. hospitals and in over 50 international markets. Information on Biosite
can be found at http://www.biosite.com.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a trademark of
Biosite Incorporated.
SOURCE Biosite Incorporated
 back to top
Related links:
http://www.biosite.com
Company News On-Call:
http://www.prnewswire.com/comp/116737.html
CONTACT:
Nadine Padilla, Vice President, Corporate and
Investor Relations of Biosite Incorporated, +1-858-805-2820,
npadilla@biosite.com
|
